Physician-reported readiness to change stroke prevention practices

Journal of Stroke and Cerebrovascular Diseases

Volumn 7, Issue 5, 1998, Pages 358-363

  Goldstein, Larry B ^a,b,c,d,e   Cohen, Staurt J ^a,b,c,d,e   Matchar, David B ^a,b,c,d,e   Bonito, Arthur J ^a,b,c,d,e   Samsa, Gregory P ^a,b,c,d,e  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

^d RTI INTERNATIONAL   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial fibrillation; Education; Endarterectomy; Prevention; Stroke

Indexed keywords

EID: 0345323770     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1052-3057(98)80055-4     Document Type: Article

References (31)

1. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-I. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 308 (1994) 81-106
2. Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study. Circulation 84 (1991) 527-539
3. Boston Area Anticoagulation for Atrial Fibrillation Investigators. The effect of low-dose wafarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 22 (1990) 1505-1558
4. Ezekowitz M.D., Bridgers S.L., James K.E., et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med 327 (1992) 1406-1412
5. EAFT Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 342 (1993) 1255-1262
6. Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II study. Lancet 343 (1994) 687-691
7. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterec tomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325 (1991) 445-453
8. European Carotid Surgery Trialists' Collaborative Group. MRC European carotid surgery trial: Interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 337 (1991) 1235-1243
9. Mayberg M.R., Wilson E., Yatsu F., et al. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. JAMA 266 (1991) 3289-3294
10. Hobson II R.W., Weiss D.G., Fields W.S., et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med 328 (1993) 221-227
11. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273 (1995) 1421-1428
12. Goldstein L.B., Bonito A.J., Matchar D.B., et al. U.S. National survey of physician practices for the secondary and tertiary prevention of stroke: Design, service availability, and common practices. Stroke 26 (1995) 1607-1615
13. Goldstein L.B., Bonito A.J., Matchar D.B., et al. US National survey of physician practices for the secondary and tertiary prevention of stroke: Medical therapy in patients with carotid artery stenosis. Stroke 27 (1996) 1473-1478
14. Munschauer F.E., Priore R.L., Hens M., et al. Thromboembolism prophylaxis in chronic atrial fibrillation-Practice patterns in community and tertiary-care hospitals. Stroke 28 (1997) 72-76
15. Albers G.W., Yim J.M., Belew K.M., et al. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals. Arch Intern Med 156 (1996) 2311-2316
16. Stafford R.S., and Singer D.E. National patterns of warfarin use in atrial fibrillation. Arch Intern Med 156 (1996) 2537-2541
17. Brass L.M., Krumholz H.M., Scinto J.M., et al. Warfarin use among patients with atrial fibrillation. Stroke 28 (1997) 2382-2389
18. abstr. Gage B.F., Boechler G., Flaker G., et al. Utilization of antithrombotic therapy in Medicare beneficiaries with nonvalvular atrial fibrillation: An opportunity lost. J Gen Intern Med 12 suppl 1 (1997) 71
19. Goldstein L.B., Bonito A.J., Matchar D.B., et al. US National survey of physician practices for the secondary and tertiary prevention of ischemic stroke: Carotid endarterectomy. Stroke 27 (1996) 801-806
20. Greco P.J., and Eisenberg J.M. Changing physician's practices. N Engl J Med 329 (1993) 1271-1274
21. Main D.S., Cohen S.J., and DiClemente C.C. Measuring physician readiness to change cancer screening: Preliminary results. Am J Prev Med 11 (1995) 54-58
22. Prochaska J.O., and DiClemente C.C. Stages and processes of self change of smoking: Toward an integrative model. J Consult Clin Psych 51 (1983) 390-395
23. DiClemente C.C., Prochaska J.O., Fairhurst S.K., et al. The process of smoking cessation: An analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psych 59 (1991) 295-304
24. Cohen S.J., Halvorson H.W., and Gosselink C.A. Changing physician behavior to improve disease prevention. Prev Med 23 (1994) 284-291
25. Shah B.V., Barnwell B.G., Hunt P.N., et al. SUDAAN User's Manual, Release 6.00 (1992), Research Triangle Institute, Research Triangle Park, NC
26. Washington, DC. US B.o.t.C. Statistical Abstract of the United States: 1992 (1992)
27. American Heart Association. 1993 Stroke Facts (1992), American Heart Association, Dallas
28. Antiplatelet Trialists' Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. BMJ 296 (1988) 320-331
29. Orlandi M.A. Promoting health and preventing disease in health care settings: An analysis of barriers. Prev Med 16 (1987) 119-130
30. Davis D.A., Thomson M.A., Oxman A.D., et al. Evidence for the effectiveness of CME. A review of 50 randomized controlled trials. JAMA 268 (1992) 1111-1117
31. Soumerai S.B., and Avorn J. Principles of educational outreach ('academic detailing') to improve clinical decision making. JAMA 263 (1990) 549-556